**Question:** Arrange the following drugs according to their half-life in increasing order: Amiodarone, Adenosine, Esmolol, Omeprazole

**Core Concept:** Half-life is a pharmacokinetic parameter that represents the time it takes for a drug to be reduced to half of its initial concentration in the body. Drugs with longer half-lives are eliminated more slowly, while those with shorter half-lives are eliminated more rapidly.

**Why the Correct Answer is Right:**

1. Omeprazole (D) has a half-life of about 2-5 hours. Omeprazole is a proton pump inhibitor used for treating gastroesophageal reflux disease (GERD), peptic ulcer disease, and erosive esophagitis. It is eliminated through the liver and kidneys, and its short half-life allows for dose adjustments and rapid therapeutic response.

2. Amiodarone (A) has a half-life of about 3-4 weeks. Amiodarone is a class III antiarrhythmic drug used for the treatment of life-threatening ventricular arrhythmias and atrial fibrillation. Its long half-life allows for a slow release of the drug, ensuring sustained therapeutic effect.

3. Adenosine (B) has a half-life of about 10-20 seconds. Adenosine is a short-acting vasodilator used for the treatment of supraventricular tachycardias, such as atrial flutter and atrial fibrillation. Its short half-life ensures prompt termination of tachycardia, but also means it must be administered repeatedly, as the effect wears off quickly.

4. Esmolol (C) has a half-life of about 2-3 minutes. Esmolol is a short-acting beta-blocker used for the treatment of tachycardia and hypertension. Its short half-life ensures rapid onset and offset of action, making it suitable for short-term control of severe hypertension or tachycardia.

**Why Each Wrong Option is Incorrect:**

1. Amiodarone's (A) long half-life makes it difficult to titrate the drug based on clinical response. This can lead to excessive adverse effects or suboptimal therapeutic outcomes.

2. Adenosine (B) has a very short half-life, which is advantageous for its rapid action but also means it needs to be administered repeatedly, potentially leading to dose-related side effects and frequent monitoring of cardiovascular parameters.

3. Esmolol (C) has a very short half-life, making it suitable for short-term control of hypertension or tachycardia but this short half-life also means it may not be suitable for long-term treatment or for patients with severe renal or hepatic impairment.

**Clinical Pearl:**

In clinical practice, understanding the pharmacokinetic properties of drugs (e.g., half-life) is crucial for safe and effective drug administration. Adenosine's short half-life makes it suitable for short-term use, but requires repeated administration. Amiodarone's long half-life ensures a sustained therapeutic effect but